Log in
Enquire now
Adaptimmune

Adaptimmune

Adaptimmune is a biotechnology company focused on the development of cancer immunotherapy products.

OverviewStructured DataIssuesContributors

Contents

adaptimmune.com
Is a
Organization
Organization
Company
Company

Company attributes

Industry
Pharmaceutical industry
Pharmaceutical industry
Research and development
Research and development
Technology
Technology
Biotechnology
Biotechnology
Biology
Biology
Internal medicine
Internal medicine
Regenerative medicine
Regenerative medicine
Medicine
Medicine
...
Location
Oxfordshire
Oxfordshire
0
Stevenage
Stevenage
0
Abingdon-on-Thames
Abingdon-on-Thames
United States
United States
United Kingdom
United Kingdom
Philadelphia
Philadelphia
0
B2X
B2B
B2B
0
CEO
‌
Adrian Rawcliffe
0
AngelList URL
angel.co/adaptimmune
Legal Name
Adaptimmune Therapeutics PLC0
Date Incorporated
2008
Number of Employees (Ranges)
201 – 500
Email Address
partnership@adaptimmune.com0
info@adaptimmune.com0
ir@adaptimmune.com0
media@adaptimmune.com0
patients@adaptimmune.com0
recruitment@adaptimmune.com0
usinfo@adaptimmune.com0
recruitmentusa@adaptimmune.com0
Phone Number
+4412354300000
Full Address
351 Rouse Boulevard Philadelphia, PA 19112 USA0
Gunnels Wood Road Stevenage Herts G1 2FX United Kingdom0
60 Jubilee Avenue Milton Park Abingdon, Oxfordshire OX14 4RX UK0
CIK Number
1,621,2270
Place of Incorporation
United Kingdom
United Kingdom
0
Investors
Rock Springs Capital
Rock Springs Capital
QVT Financial
QVT Financial
‌
Merlin Nexus
Ally Bridge Group
Ally Bridge Group
Ridgeback Capital
Ridgeback Capital
Genentech
Genentech
venBio
venBio
Founded Date
2008
Fax Number
+44 (0) 1235 4300010
Stock Symbol
ADAP0
Exchange
Nasdaq
Nasdaq
0
CFO
‌
Gavin Wood
0
Patents Assigned (Count)
8
Wellfound ID
adaptimmune
Country
United Kingdom
United Kingdom
0
United States
United States
0

Other attributes

Company Operating Status
Active
Previous Name
Adaptimmune Ltd0
SIC Code
2,8360
Wikidata ID
Q30260262
No article content yet.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title
Author
Link
Type
Date

Adaptimmune Therapeutics plc Announces Closing of Registered Direct Offering of American Depositary Shares

Adaptimmune Therapeutics plc

https://www.globenewswire.com/news-release/2018/09/07/1568112/0/en/Adaptimmune-Therapeutics-plc-Announces-Closing-of-Registered-Direct-Offering-of-American-Depositary-Shares.html

Web

References

Find more companies like Adaptimmune

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us